- Home
- / Jeisys Medical
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Jeisys Medical financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Revenue
₩143 B
FY, 2023
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| KRW | FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | FY, 2022 | FY, 2023 |
|---|---|---|---|---|---|---|
| Revenue | 81.3B | 116.5B | 143.0B | |||
| Cost of goods sold | 23.2B | 33.2B | 43.2B | |||
| Gross profit | 58.5B | 83.4B | 99.9B | |||
| Gross profit margin, % | 72.0% | 71.6% | 69.9% | |||
| Operating expense total | 66.2M | 53.5M | 102.4M | 32.1B | 46.3B | 59.2B |
| Depreciation and amortization | 2.4B | 3.0B | 4.3B | |||
| EBITDA | (66.2M) | (53.5M) | (102.4M) | 26.5B | 37.2B | 40.7B |
| EBITDA margin, % | 32.6% | 31.9% | 28.5% | |||
| EBIT | (66.2M) | (53.5M) | (102.4M) | 13.2B | 33.8B | 36.3B |
| EBIT margin, % | 16.2% | 29.0% | 25.4% | |||
| Interest income | 84.6M | 124.6M | 99.4M | 32.6M | 33.1M | 121.8M |
| Interest expense | 23.4M | 24.4M | 25.4M | 388.0M | 391.2M | 222.4M |
| Pre tax profit | (5.0M) | 46.7M | (28.4M) | 13.1B | 33.9B | 35.5B |
| Income tax expense | 1.1M | 7.1M | (7.2M) | (667.1M) | 6.9B | 10.4B |
| Net Income | (6.0M) | 39.6M | (21.2M) | 13.8B | 27.0B | 25.1B |